Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | -15 |
| Ticker | MYX |
| Latest Price | 5.07 AUD as of close on 04-Jul-2025 |
| 3 Month price range | 4.35 to 7.15 AUD |
| Market Capitalisation | 412.73Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| Description | Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women's Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia. See More ... |
| Company URL | https://www.maynepharma.com |
| See Darwins Full Analysis for Mayne Pharma Group Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Mayne Pharma Group Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -10 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -6 |
There are 4 live alerts for Mayne Pharma Group Ltd.
There are 6 peers of Mayne Pharma Group Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Cann Group Ltd (CAN) | Pharmaceuticals | +30.8 | 0 |
| Ecofibre Ltd (EOF) | Pharmaceuticals | 0 | -8 |
| Firebrick Pharma Ltd (FRE) | Pharmaceuticals | -6.0 | -12 |
| Medical Developments International Ltd (MVP) | Pharmaceuticals | -2.0 | +9 |
| Neuren Pharmaceuticals Ltd (NEU) | Pharmaceuticals | +2.7 | +42 |
| Starpharma Holdings Ltd (SPL) | Pharmaceuticals | -3.2 | -15 |
To see complete information on Mayne Pharma Group Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |